• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Reports First Quarter 2024 Financial Results

    5/7/24 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email

    Achieves Record Quarterly Net Sales of $137.9 Million and Gross Profit of $57.6 Million

    Reaffirms 2024 Full-Year Guidance

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2024.

    • Net sales of $137.9 million for the first quarter
    • Gross profit margin of 41.8% for the first quarter
    • Net income of $6.9 million, or $0.18 per diluted share, for the first quarter
    • Adjusted EBITDA of $24.5 million for the first quarter
    • Adjusted EBITDA margin of 17.8% for the first quarter
    • Declared quarterly cash dividend of $0.0875 per share in April 2024.

    "Building on a year of record net sales and Adjusted EBITDA, we continued to successfully increase net sales and gross margin sequentially and year over year," said Warren Kanders, CEO and Chairman. "The effectiveness of our operating model and resilience of our businesses was evident, highlighted by Q1 net sales growth of 23% and Adjusted EBITDA margin improvement of 120 basis points versus last year. Based on strong and recurring demand for our mission-critical safety equipment, underpinned by positive industry fundamentals, we have reaffirmed our full-year guidance and look forward to continuing to deliver on our strategic objectives."

    "During the first quarter, we completed the acquisitions of ICOR Technology and Alpha Safety, two leading high-margin safety businesses, representing important progress expanding and diversifying our platform. We believe there are additional attractive opportunities in our M&A funnel to accelerate growth. We will continue to focus on our current verticals, which include the law enforcement, military and nuclear markets in the near future and believe there are ample targets to drive continued growth in the business. Patience and discipline have always been hallmarks of our approach, and we remain committed to evaluating M&A consistent with our highly selective key criteria focused on companies with strong margins, leading and defensible market positions, along with recurring revenues and cash flows."

    First Quarter 2024 Operating Results

    For the quarter ended March 31, 2024, Cadre generated net sales of $137.9 million, as compared to $111.7 million for the quarter ended March 31, 2023. This increase was primarily a result of recent acquisitions, higher demand for armor products and EOD products and increased agency demand for hard goods through our Distribution segment.

    For the quarter ended March 31, 2024, Cadre generated gross profit of $57.6 million, as compared to $46.6 million for the quarter ended March 31, 2023.

    Gross profit margin was 41.8% for the quarter ended March 31, 2024, as compared to 41.7% for the quarter ended March 31, 2023, mainly driven by favorable pricing and mix, offset by amortization of inventory step up adjustments related to acquisition and inflation.

    Net income was $6.9 million for the quarter ended March 31, 2024, as compared to net income of $7.0 million for the quarter ended March 31, 2023. The decrease resulted primarily from an increase in selling, general and administrative expenses due to acquisitions and transaction expenses, partially offset by an increase in gross profit and recent acquisitions.

    Cadre generated $24.5 million of Adjusted EBITDA for the quarter ended March 31, 2024, as compared to $18.6 million for the quarter ended March 31, 2023. Adjusted EBITDA margin was 17.8% for the quarter ended March 31, 2024, as compared to 16.6% for the prior year period.

    Product segment gross profit margin was 43.0% for the first quarter, compared to 43.6% for the prior year period.

    Distribution segment gross profit margin was 23.5% for the first quarter, compared to 24.2% for the prior year period.

    Liquidity, Cash Flows and Capital Allocation

    • Cash and cash equivalents decreased by $0.6 million from $87.7 million as of December 31, 2023 to $87.1 million as of March 31, 2024.
    • Total debt increased by $75.7 million from $140.1 million as of December 31, 2023 to $215.8 million as of March 31, 2024.
    • Net debt (total debt net of cash and cash equivalents) increased by $76.3 million from $52.4 million as of December 31, 2023 to $128.8 million as of March 31, 2024.
    • Capital expenditures totaled $1.3 million for the three months ended March 31, 2024, compared with $0.8 million for the three months ended March 31, 2023.

    Dividend

    On April 23, 2024, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.0875 per share, or $0.35 per share on an annualized basis. Cadre's dividend payment will be made on May 17, 2024 to shareholders of record as of the close of business on the record date of May 3, 2024. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.

    Acquisition of ICOR Technology

    On January 9, 2024, Cadre completed its acquisition of ICOR Technology, a leading manufacturer and distributor of EOD and tactical robots and specialized protective security equipment for EOD and military organizations worldwide.

    Acquisition of Alpha Safety

    On March 1, 2024, Cadre completed its accretive acquisition of Alpha Safety, a leading nuclear safety solutions company.

    2024 Outlook

    For the full year 2024, Cadre expects to generate net sales in the range of $553 million to $572 million and Adjusted EBITDA in the range of $104 million and $108 million. We expect capital expenditures to be in the range of $8 million to $10 million.

    Conference Call

    Management will host a conference call on Tuesday, May 7, 2024, at 5:00 PM EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (888)-596-4144 and the dial-in number for international callers is 646-968-2525. The access code for all callers is 3272793. A live webcast will also be available on the Company's website at https://www.cadre-holdings.com/.

    A replay of the call will be available through May 21, 2024. To access the replay, please dial 800-770-2030 in the U.S. or +1-609-800-9909 if outside the U.S., and then enter the access code 3272793.

    About Cadre

    Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety products. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

    Use of Non-GAAP Measures

    The Company reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization ("EBITDA"), (ii) adjusted EBITDA, (iii) adjusted EBITDA margin and (iv) last twelve months adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user's overall understanding of the Company's current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. We do not provide a reconciliation of the non-GAAP guidance measure Adjusted EBITDA for the fiscal year 2024 to net income for the fiscal year 2024, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not Adjusted EBITDA. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

    Forward-Looking Statements

    Please note that in this press release we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, those risks and uncertainties more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled "Risk Factors" in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company's Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward- looking statements to reflect events or circumstances after the date of this press release.

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

    March 31, 2024

     

    December 31, 2023

    Assets

     

     

     

     

     

     

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    87,052

     

     

    $

    87,691

     

    Accounts receivable, net of allowance for doubtful accounts of $1,087 and $635, respectively

     

     

    68,107

     

     

     

    58,360

     

    Inventories

     

     

    95,759

     

     

     

    80,976

     

    Prepaid expenses

     

     

    12,365

     

     

     

    11,930

     

    Other current assets

     

     

    6,045

     

     

     

    6,886

     

    Total current assets

     

     

    269,328

     

     

     

    245,843

     

    Property and equipment, net of accumulated depreciation and amortization of $49,904 and $50,968, respectively

     

     

    46,709

     

     

     

    44,647

     

    Operating lease assets

     

     

    9,987

     

     

     

    6,554

     

    Deferred tax assets, net

     

     

    3,969

     

     

     

    4,004

     

    Intangible assets, net

     

     

    115,011

     

     

     

    43,472

     

    Goodwill

     

     

    148,912

     

     

     

    81,667

     

    Other assets

     

     

    5,526

     

     

     

    4,992

     

    Total assets

     

    $

    599,442

     

     

    $

    431,179

     

     

     

     

     

     

     

     

    Liabilities, Mezzanine Equity and Shareholders' Equity

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Accounts payable

     

    $

    30,282

     

     

    $

    28,418

     

    Accrued liabilities

     

     

    47,467

     

     

     

    44,524

     

    Income tax payable

     

     

    2,573

     

     

     

    9,944

     

    Current portion of long-term debt

     

     

    15,234

     

     

     

    12,320

     

    Total current liabilities

     

     

    95,556

     

     

     

    95,206

     

    Long-term debt

     

     

    200,601

     

     

     

    127,812

     

    Long-term operating lease liabilities

     

     

    5,822

     

     

     

    3,186

     

    Deferred tax liabilities

     

     

    21,554

     

     

     

    4,843

     

    Other liabilities

     

     

    5,208

     

     

     

    2,970

     

    Total liabilities

     

     

    328,741

     

     

     

    234,017

     

     

     

     

     

     

     

     

    Mezzanine equity

     

     

     

     

     

     

    Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2024 and December 31, 2023)

     

     

    —

     

     

     

    —

     

     

     

     

     

     

     

     

    Shareholders' equity

     

     

     

     

     

     

    Common stock ($0.0001 par value, 190,000,000 shares authorized, 40,060,444 and 37,587,436 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively)

     

     

    4

     

     

     

    4

     

    Additional paid-in capital

     

     

    282,176

     

     

     

    212,630

     

    Accumulated other comprehensive income

     

     

    988

     

     

     

    634

     

    Accumulated deficit

     

     

    (12,467

    )

     

     

    (16,106

    )

    Total shareholders' equity

     

     

    270,701

     

     

     

    197,162

     

    Total liabilities, mezzanine equity and shareholders' equity

     

    $

    599,442

     

     

    $

    431,179

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31,

     

     

    2024

     

    2023

    Net sales

     

    $

    137,860

     

     

    $

    111,748

     

    Cost of goods sold

     

     

    80,232

     

     

     

    65,130

     

    Gross profit

     

     

    57,628

     

     

     

    46,618

     

    Operating expenses

     

     

     

     

     

     

    Selling, general and administrative

     

     

    40,719

     

     

     

    35,250

     

    Restructuring and transaction costs

     

     

    3,087

     

     

     

    —

     

    Related party expense

     

     

    1,843

     

     

     

    148

     

    Total operating expenses

     

     

    45,649

     

     

     

    35,398

     

    Operating income

     

     

    11,979

     

     

     

    11,220

     

    Other expense

     

     

     

     

     

     

    Interest expense

     

     

    (1,637

    )

     

     

    (1,641

    )

    Other (expense) income, net

     

     

    (1,444

    )

     

     

    364

     

    Total other expense, net

     

     

    (3,081

    )

     

     

    (1,277

    )

    Income before provision for income taxes

     

     

    8,898

     

     

     

    9,943

     

    Provision for income taxes

     

     

    (1,970

    )

     

     

    (2,941

    )

    Net income

     

    $

    6,928

     

     

    $

    7,002

     

     

     

     

     

     

     

     

    Net income per share:

     

     

     

     

     

     

    Basic

     

    $

    0.18

     

     

    $

    0.19

     

    Diluted

     

    $

    0.18

     

     

    $

    0.19

     

    Weighted average shares outstanding:

     

     

     

     

     

     

    Basic

     

     

    37,946,576

     

     

     

    37,373,529

     

    Diluted

     

     

    38,554,185

     

     

     

    37,629,498

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31,

     

     

    2024

     

    2023

    Cash Flows From Operating Activities:

     

     

     

     

     

     

    Net income

     

    $

    6,928

     

     

    $

    7,002

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

    Depreciation and amortization

     

     

    3,942

     

     

     

    4,261

     

    Amortization of original issue discount and debt issue costs

     

     

    149

     

     

     

    64

     

    Amortization of inventory step-up

     

     

    769

     

     

     

    —

     

    Deferred income taxes

     

     

    1,546

     

     

     

    183

     

    Stock-based compensation

     

     

    2,067

     

     

     

    2,747

     

    Remeasurement of contingent consideration

     

     

    451

     

     

     

    —

     

    Provision for losses on accounts receivable

     

     

    480

     

     

     

    40

     

    Foreign exchange loss (gain)

     

     

    934

     

     

     

    (213

    )

    Other loss (gain)

     

     

    52

     

     

     

    (103

    )

    Changes in operating assets and liabilities, net of impact of acquisitions:

     

     

     

     

     

     

    Accounts receivable

     

     

    2,696

     

     

     

    9,075

     

    Inventories

     

     

    1,818

     

     

     

    (5,830

    )

    Prepaid expenses and other assets

     

     

    2,028

     

     

     

    (556

    )

    Accounts payable and other liabilities

     

     

    (21,723

    )

     

     

    (3,948

    )

    Net cash provided by operating activities

     

     

    2,137

     

     

     

    12,722

     

    Cash Flows From Investing Activities:

     

     

     

     

     

     

    Purchase of property and equipment

     

     

    (1,343

    )

     

     

    (781

    )

    Proceeds from disposition of property and equipment

     

     

    —

     

     

     

    201

     

    Business acquisitions, net of cash acquired

     

     

    (141,293

    )

     

     

    —

     

    Net cash used in investing activities

     

     

    (142,636

    )

     

     

    (580

    )

    Cash Flows From Financing Activities:

     

     

     

     

     

     

    Proceeds from revolving credit facilities

     

     

    5,500

     

     

     

    —

     

    Principal payments on revolving credit facilities

     

     

    (5,500

    )

     

     

    —

     

    Proceeds from term loans

     

     

    80,000

     

     

     

    —

     

    Principal payments on term loans

     

     

    (2,500

    )

     

     

    (2,500

    )

    Principal payments on insurance premium financing

     

     

    (1,083

    )

     

     

    (1,092

    )

    Payments for debt issuance costs

     

     

    (844

    )

     

     

    —

     

    Taxes paid in connection with employee stock transactions

     

     

    (5,311

    )

     

     

    (2,725

    )

    Proceeds from secondary offering, net of underwriter discounts

     

     

    73,535

     

     

     

    —

     

    Deferred offering costs

     

     

    (722

    )

     

     

    —

     

    Dividends distributed

     

     

    (3,289

    )

     

     

    (2,986

    )

    Net cash provided by (used in) financing activities

     

     

    139,786

     

     

     

    (9,303

    )

    Effect of foreign exchange rates on cash and cash equivalents

     

     

    74

     

     

     

    169

     

    Change in cash and cash equivalents

     

     

    (639

    )

     

     

    3,008

     

    Cash and cash equivalents, beginning of period

     

     

    87,691

     

     

     

    45,286

     

    Cash and cash equivalents, end of period

     

    $

    87,052

     

     

    $

    48,294

     

    Supplemental Disclosure of Cash Flows Information:

     

     

     

     

     

     

    Cash paid for income taxes, net

     

    $

    9,369

     

     

    $

    3,141

     

    Cash paid for interest

     

    $

    2,498

     

     

    $

    2,359

     

    Supplemental Disclosure of Non-Cash Investing and Financing Activities:

     

     

     

     

     

     

    Accruals and accounts payable for capital expenditures

     

    $

    210

     

     

    $

    238

     

    CADRE HOLDINGS, INC.

    SEGMENT INFORMATION

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    118,785

     

    $

    28,191

     

    $

    (9,116

    )

     

    $

    137,860

    Cost of goods sold

     

     

    67,764

     

     

    21,557

     

     

    (9,089

    )

     

     

    80,232

    Gross profit

     

    $

    51,021

     

    $

    6,634

     

    $

    (27

    )

     

    $

    57,628

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31, 2023

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    93,194

     

    $

    24,660

     

    $

    (6,106

    )

     

    $

    111,748

    Cost of goods sold

     

     

    52,608

     

     

    18,697

     

     

    (6,175

    )

     

     

    65,130

    Gross profit

     

    $

    40,586

     

    $

    5,963

     

    $

    69

     

     

    $

    46,618

    ______________________

    (1)

    Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

    CADRE HOLDINGS, INC.

    RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

    (Unaudited)

    (In thousands)

     

     

     

    Year ended

     

    Three Months Ended

     

    Last Twelve

     

     

    December 31,

     

    March 31,

     

    Months

     

     

    2023

     

    2024

     

    2023

     

    March 31, 2024

    Net income

     

    $

    38,641

     

     

    $

    6,928

     

    $

    7,002

     

     

    $

    38,567

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    15,737

     

     

     

    3,942

     

     

    4,261

     

     

     

    15,418

     

    Interest expense

     

     

    4,531

     

     

     

    1,637

     

     

    1,641

     

     

     

    4,527

     

    Provision for income taxes

     

     

    14,283

     

     

     

    1,970

     

     

    2,941

     

     

     

    13,312

     

    EBITDA

     

    $

    73,192

     

     

    $

    14,477

     

    $

    15,845

     

     

    $

    71,824

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and transaction costs(1)

     

     

    3,192

     

     

     

    4,837

     

     

    —

     

     

     

    8,029

     

    Other general income(2)

     

     

    (92

    )

     

     

    —

     

     

    —

     

     

     

    (92

    )

    Other (income) expense, net(3)

     

     

    (936

    )

     

     

    1,444

     

     

    (364

    )

     

     

    872

     

    Stock-based compensation expense(4)

     

     

    9,368

     

     

     

    2,067

     

     

    2,747

     

     

     

    8,688

     

    Stock-based compensation payroll tax expense(5)

     

     

    234

     

     

     

    393

     

     

    220

     

     

     

    407

     

    LTIP bonus(6)

     

     

    860

     

     

     

    50

     

     

    144

     

     

     

    766

     

    Amortization of inventory step-up(7)

     

     

    —

     

     

     

    769

     

     

    —

     

     

     

    769

     

    Contingent consideration expense(8)

     

     

    —

     

     

     

    451

     

     

    —

     

     

     

    451

     

    Adjusted EBITDA

     

    $

    85,818

     

     

    $

    24,488

     

    $

    18,592

     

     

    $

    91,714

     

    Adjusted EBITDA margin(9)

     

     

    16.5

     

    %

     

    17.8

    %

     

    16.6

     

    %

     

     

    ______________________

    (1)

    Reflects the "Restructuring and transaction costs" line item on our consolidated statement of operations and comprehensive income, which primarily includes transaction costs composed of legal and consulting fees. In addition, this line item reflects a $1.0 million transaction fee payable to Kanders & Company, Inc. for services related to the acquisition of ICOR that was accrued for during the year ended December 31, 2023 and a $1.8 million transaction fee paid to Kanders & Company, Inc. for services related to the acquisition of Alpha Safety for the three months ended March 31, 2024, which are included in related party expense in the Company's consolidated statements of operations. Kanders & Company, Inc. is a company controlled by Warren B. Kanders, our Chairman of the Board and Chief Executive Officer.

     

    (2)

    Reflects gains from long-lived asset sales.

     

    (3)

    Reflects the "Other income (expense), net" line item on our consolidated statements of operations and primarily includes gains and losses due to fluctuations in foreign currency exchange rates.

     

    (4)

    Reflects compensation expense related to equity and liability classified stock-based compensation plans.

     

    (5)

    Reflects payroll taxes associated with vested stock-based compensation awards.

     

    (6)

    Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

     

    (7)

    Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions.

     

    (8)

    Reflects contingent consideration expense related to the acquisition of ICOR.

     

    (9)

    Reflects Adjusted EBITDA / Net sales for the relevant periods.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240507465810/en/

    Get the next $CDRE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    8/13/2025$26.00Neutral → Underperform
    BofA Securities
    6/13/2025$38.00Buy → Neutral
    BofA Securities
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    More analyst ratings

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Neutral to Underperform and set a new price target of $26.00

    8/13/25 8:01:40 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Buy to Neutral and set a new price target of $38.00

    6/13/25 7:45:51 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ROTH MKM reiterated coverage on Cadre Holdings with a new price target

    ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

    2/21/24 9:51:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cadre Holdings Completes Acquisition of TYR Tactical

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, has completed the Company's previously announced acquisition of TYR Tactical, LLC, a leading global manufacturer of tactical gear and equipment for military, law enforcement, and government agencies worldwide. The purchase price consisted of $120.0 million of cash and $24.0 million of Cadre common stock, as well as $1.0 million of Cadre common stock in the form of restricted stock unit awards to be granted to certain employees of TYR Tactical1. In addition, t

    2/2/26 8:30:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Increases Dividend

    Declares Quarterly Dividend of $0.10 Per Share; ~5% Increase on Annualized Basis Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share, or $0.40 per share on an annualized basis, on the Company's common stock. On an annualized basis, the newly declared cash dividend represents an increase of 2 cents, or approximately 5%, over the previous annualized dividend of $0.38 per share. Cadre's dividend payment will be m

    1/20/26 4:42:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Participate in CJS Securities 26th Annual New Ideas for the New Year Conference

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that Brad Williams, President, and Blaine Browers, Chief Financial Officer, are scheduled to present at the CJS Securities 26th Annual New Ideas for the New Year Conference on Wednesday, January 14, 2026 at 10:15 a.m. ET. Cadre management will also participate in investor meetings held in conjunction with the conference. The presentation will be available via a live listen-only webcast and can be accessed through the Investor Relations section

    1/6/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Financials

    Live finance-specific insights

    View All

    Cadre Holdings Increases Dividend

    Declares Quarterly Dividend of $0.10 Per Share; ~5% Increase on Annualized Basis Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share, or $0.40 per share on an annualized basis, on the Company's common stock. On an annualized basis, the newly declared cash dividend represents an increase of 2 cents, or approximately 5%, over the previous annualized dividend of $0.38 per share. Cadre's dividend payment will be m

    1/20/26 4:42:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Reports Third Quarter 2025 Financial Results

    Grew Quarterly Net Sales 42% and Gross Profit 66% Year-Over-Year Increased Quarterly Adjusted EBITDA of $29.8 Million and Expanded Adjusted EBITDA Margin of 19.1% Organic Backlog Increased $20 Million from Q2 to Q3 Med-Eng Awarded $50 Million IDIQ with DoD – First PO issued for $10 Million to be Shipped in 2026 Agrees to Acquire TYR Tactical, Leading Provider of Plate Carriers, Vests, Hard Armor, and Shields Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results f

    11/4/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Acquire TYR Tactical

    Leading Provider of Plate Carriers, Vests, Hard Armor, and Shields to Tactical Teams Expected to be Immediately Accretive and Advances Strategic Focus on Mission-Critical Products with High Margins, Strong Cash Flows Provides Significant Entry into New Markets, Particularly in European Military and Defense Management Will Host a Conference Call at 10 a.m. ET to Discuss the Transaction Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today it has entered into a definitive agreement to acquire

    10/29/25 6:00:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO AND CHAIRMAN Kanders Warren B gifted 12,250 shares (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    12/29/25 4:15:16 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CHIEF FINANCIAL OFFICER Browers Blaine sold $894,849 worth of shares (20,435 units at $43.79), decreasing direct ownership by 24% to 63,142 units (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    12/16/25 4:15:25 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    PRESIDENT Williams Brad sold $1,031,760 worth of shares (24,000 units at $42.99), decreasing direct ownership by 30% to 54,719 units (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    12/12/25 4:15:36 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    View All

    Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

    1/13/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

    4/12/22 8:30:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

    VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

    4/7/22 8:05:00 AM ET
    $CDRE
    $SOLO
    Industrial Specialties
    Health Care
    Auto Manufacturing
    Consumer Discretionary

    $CDRE
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Cadre Holdings Inc.

    SCHEDULE 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/26 4:13:47 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

    SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/5/26 1:20:38 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Amendment: Cadre Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K/A - Cadre Holdings, Inc. (0001860543) (Filer)

    2/2/26 8:30:46 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    11/12/24 9:50:14 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/24 7:58:49 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/24 4:15:31 PM ET
    $CDRE
    Industrial Specialties
    Health Care